Calcium release-activated calcium channel modulators for treating hematological and solid cancers

• 收藏
• 分享

专利权人:

Rhizen Pharmaceuticals SA

发明人:

VISWANADHA, Srikant,VAKKALANKA, Swaroop Kumar Venkata Satya

申请号：

AU2018360367

公开号：

AU2018360367A1

申请日:

2018.10.29

申请国别(地区):

AU

年份:

2020

代理人:

摘要：

The present invention relates to the use of a calcium release-activated calcium (CRAC) channel modulator, such as N-[4-(3,5-dicyclopropyl-1H-pyrazol-1-yl)phenyl]-2-(quinolin-6-yl)acetamide (Compound (A)) or a pharmaceutically acceptable salt thereof, or a pharmaceutical composition containing such a CRAC channel modulator for the treatment of haematological and solid cancers.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/